Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
hubergroup’s two newly added medical vans are dedicated to dental and eye care
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Proposed combination enhances Pfizer’s position as a leading company in oncology
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Digital success is contingent on the way a company organizes itself around technology
Subscribe To Our Newsletter & Stay Updated